Table 4.
Effect of baseline cognition on non-remission status at two-year follow-up in CHR participants.
| CHR-R (N = 49) |
CHR-NR (N = 96) |
Effect size (odds ratio) | 95% CI | p-value | |
|---|---|---|---|---|---|
| Verbal memory (M, SD) | |||||
| Immediate recalla | 51.90 (8.62) | 49.83 (10.74) | 0.54 | 0.34, 0.85 | 0.008⁎⁎ |
| Delayed recallb | 10.42 (2.42) | 10.38 (2.95) | 0.86 | 0.46, 1.58 | 0.621 |
| Verbal fluency (M, SD) | |||||
| Phonemic fluencyc | 34.16 (12.11) | 36.21 (12.86) | 0.68 | 0.40, 1.15 | 0.152 |
| Semantic fluencyd | 22.43 (6.06) | 21.46 (6.34) | 0.90 | 0.50, 1.63 | 0.722 |
Model 1 for each analysis adjusting for age, gender, and site.
Data was missing for: a6 CHR-NR and 1 CHR-R; b7 CHR-NR and 1 CHR-R; c2 CHR-NR; d2 CHR-NR.
⁎⁎
p-value <0.01.